A Single Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years Later

2006 ◽  
Vol 2006 ◽  
pp. 152-153
Author(s):  
T.J. Fahey
Thyroid ◽  
2005 ◽  
Vol 15 (2) ◽  
pp. 158-164 ◽  
Author(s):  
Alessia David ◽  
Annabella Blotta ◽  
Roberta Rossi ◽  
Maria Chiara Zatelli ◽  
Marta Bondanelli ◽  
...  

Thyroid ◽  
2005 ◽  
Vol 15 (3) ◽  
pp. 267-273 ◽  
Author(s):  
Alessia David ◽  
Annabella Blotta ◽  
Roberta Rossi ◽  
Maria Chiara Zatelli ◽  
Marta Bondanelli ◽  
...  

1987 ◽  
Vol 26 (03) ◽  
pp. 139-142 ◽  
Author(s):  
G. Arning ◽  
O. Schober ◽  
H. Hundeshagen ◽  
Ch. Ehrenheim

In the follow-up of differentiated thyroid carcinoma it is discussed whether the tumormarker thyroglobulin can replace the1311 scan, especially when the thyroglobulin serum level is normal. A positive1311 scan of metastases in the follow-up of patients with differentiated thyroid carcinoma combined with a low serum thyroglobulin level is extremely rare. The literature shows a frequency of about 4%. Recently we found 3 cases with a positive1311 scan demonstrating pulmonary and bone metastases whereas the serum thyroglobulin level was low.


Sign in / Sign up

Export Citation Format

Share Document